WFH NETWORK

Spain

Country: Spain
City: Valencia

IHTC:
Haemostasis and Thrombosis Unit
Haematology Service, University and Polytechnic Hospital La Fe
Bulevar Sur  s/n, Valencia, Spain, 46026
Tel.: 34 961244865
Email: sbonanad@gmail.com

Director: Santiago Bonanad
Medical Associates: Haematologists: Santiago Bonanand, Ana Cid, Saturnino Haya; Rehabilitation medicine: Felipe Querol; Physiotherapists: Sofía Pérez, Marlene Jaca; Biochemistry: Noelia Cabrera and Andrés Moret; Psychologists: María Garcia Dasí
Fellowship logistics coordinator: Fina Sánchez (sanchez_josriu@gva.es)
Year of IHTC designation: 1997

Areas of specialty: Adult and pediatric hematology; Laboratory diagnosis and hemostasis; Molecular genetics; Nursing; Orthopedic care and surgery; Physiotherapy; Blood banking; Psychology and Social services

DESCRIPTION OF IHTC FACILITIES

Location: La Fe University Hospital (Congenital Coagulopathy Unit), in Valencia - Spain

Climate: Typically Mediterranean. Very few rainy days, occurring mainly in autumn, the winter is mild (temperature is never below 0ºC), Autumn and spring are warm and summer is very hot, with both high temperatures and humidity levels (35-40º C degrees and 50-80% humidity)

Accommodation (residence, meals, etc...): There is a residence for university students and teachers located in the centre of the city, 25 minutes from the hospital. The residence also offers full board.

Language: Spanish and English

DESCRIPTION OF TRAINING PROGRAM

Clinical activities: Comprehensive hemophilia care (simultaneous hematologic and musculoskeletal care); epidemiologic inhibitor study and immune tolerance treatment in haemophilia A; primary prophylaxis; synoviorthesis; joint evaluation (clinical-radiological criteria); comprehensive care in von Willebrand disease; comprehensive care other coagulopathies. The staff is composed of four hematologists, three biologists and two technicians, three nurses and two auxiliary nurses, one psychologists and one data manager.

Patients comprise as follows: 351 hemophilia A, 37 hemophilia B, 257 von Willebrand disease, 307 rare bleeding disorders, and 541 hemophilia carriers.

Laboratory activities/research: General laboratory diagnose of most coagulopathies (use of clotting, chromogenic and antigenic methods). Laboratory diagnose of von Willebrand disease (ristocetin cofactor, RIPA, collagen binding assay, FVIII binding assay, antigen of VWF, multimeric pattern). Inhibitor screening and titration (Kasper test, Bethesda and Nijmegen assays). Western blot of FVIII for epitope mapping of anti-FVIII antibodies (specificity against light or heavy chain of FVIII). Direct/indirect genetic diagnose for hemophilia A, B and von Willebrand disease.

Multidisciplinary activities/research: Training program treatment for fathers; training program on self-treatment for patients; program on strength improvement and care of musculoskeletal system; sport and hemophilia program; special program for swimming in hemophilia.

To see a sample curriculum of the multidisciplinary training that will be provided, please click here.


Updated July 2014